Resultats de la cerca - Pluard, Timothy
- Mostrar 1 - 20 resultats de 22
- Anar a la pàgina següent
-
1
Diffuse Large B-cell Lymphoma Presenting as Bilateral Renal Masses: Successful Treatment with Dose-adjusted REPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide,... per Kaur, Anahat, Abughanimeh, Omar, Zafar, Yousaf, Pluard, Timothy
Publicat 2019Text -
2
-
3
-
4
A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer per Roop, Ryan P., Naughton, Michael J., Van Poznak, Catherine, Schneider, Jochen G., Lammers, Philip E., Pluard, Timothy J., Johnson, Farley, Eby, Charles S., Weilbaecher, Katherine N.
Publicat 2013Text -
5
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor Positive Metastatic Breast Cancer per Ma, Cynthia X., Sanchez, Cesar, Gao, Feng, Crowder, Robert, Naughton, Michael, Pluard, Timothy, Creekmore, Allison, Guo, Zhanfang, Hoog, Jeremy, Lockhart, A. Craig, Doyle, Laurence, Erlichman, Charles, Ellis, Matthew J.
Publicat 2016Text -
6
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice per Imperial, Robin, Nazer, Marjan, Ahmed, Zaheer, Kam, Audrey E., Pluard, Timothy J., Bahaj, Waled, Levy, Mia, Kuzel, Timothy M., Hayden, Dana M., Pappas, Sam G., Subramanian, Janakiraman, Masood, Ashiq
Publicat 2019Text -
7
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603) per O'Reilly, Eileen M., Niedzwiecki, Donna, Hall, Margaret, Hollis, Donna, Bekaii-Saab, Tanios, Pluard, Timothy, Douglas, Kathe, Abou-Alfa, Ghassan K., Kindler, Hedy L., Schilsky, Richard L., Goldberg, Richard M.
Publicat 2010Text -
8
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer per Ma, Cynthia X., Suman, Vera J., Goetz, Matthew, Haluska, Paul, Moynihan, Timothy, Nanda, Rita, Olopade, Olufunmilayo, Pluard, Timothy, Guo, Zhanfang, Chen, Helen X., Erlichman, Charles, Ellis, Matthew J., Fleming, Gini F.
Publicat 2013Text -
9
Phase II trial of temsirolimus in patients with metastatic breast cancer per Fleming, Gini F., Ma, Cynthia X., Huo, Dezheng, Sattar, Husain, Tretiakova, Maria, Lin, L., Hahn, Olwen M., Olopade, F. O., Nanda, R., Hoffman, Philip C., Naughton, M. J., Pluard, Timothy, Conzen, Suzanne D., Ellis, Matthew J.
Publicat 2012Text -
10
Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles per Imperial, Robin, Ahmed, Zaheer, Toor, Omer M., Erdoğan, Cihat, Khaliq, Ateeq, Case, Paul, Case, James, Kennedy, Kevin, Cummings, Lee S., Melton, Niklas, Raza, Shahzad, Diri, Banu, Mohammad, Ramzi, El-Rayes, Bassel, Pluard, Timothy, Hussain, Arif, Subramanian, Janakiraman, Masood, Ashiq
Publicat 2018Text -
11
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Resp... per Sikov, William M., Berry, Donald A., Perou, Charles M., Singh, Baljit, Cirrincione, Constance T., Tolaney, Sara M., Kuzma, Charles S., Pluard, Timothy J., Somlo, George, Port, Elisa R., Golshan, Mehra, Bellon, Jennifer R., Collyar, Deborah, Hahn, Olwen M., Carey, Lisa A., Hudis, Clifford A., Winer, Eric P.
Publicat 2015Text -
12
A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer per Ma, Cynthia X., Luo, Jingqin, Naughton, Michael, Ademuyiwa, Foluso, Suresh, Rama, Griffith, Malachi, Griffith, Obi L., Skidmore, Zachary L., Spies, Nicholas C., Ramu, Avinash, Trani, Lee, Pluard, Timothy, Nagaraj, Gayathri, Thomas, Shana, Guo, Zhanfang, Hoog, Jeremy, Han, Jing, Mardis, Elaine, Lockhart, Craig, Ellis, Matthew J.
Publicat 2015Text -
13
CXCR4 Protein Epitope Mimetic Antagonist, POL5551, Disrupts Metastasis and Enhances Chemotherapy Effect in Triple Negative Breast Cancer per Xiang, Jingyu, Hurchla, Michelle A., Fontana, Francesca, Su, Xinming, Amend, Sarah R., Esser, Alison K., Douglas, Garry J., Mudalagiriyappa, Chidananda, Luker, Kathryn E., Pluard, Timothy, Ademuyiwa, Foluso O., Romagnoli, Barbara, Tuffin, Gérald, Chevalier, Eric, Luker, Gary D., Bauer, Michael, Zimmermann, Johann, Aft, Rebecca L., Dembowsky, Klaus, Weilbaecher, Katherine N.
Publicat 2015Text -
14
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial per Aft, Rebecca, Naughton, Michael, Trinkaus, Kathryn, Watson, Mark, Ylagan, Lourdes, Chavez-MacGregor, Mariana, Zhai, Jing, Kuo, Sacha, Shannon, William, Diemer, Kathryn, Herrmann, Virginia, Dietz, Jill, Ali, Amjad, Ellis, Matthew, Weiss, Peter, Eberlein, Timothy, Ma, Cynthia, Fracasso, Paula M, Zoberi, Imran, Taylor, Marie, Gillanders, William, Pluard, Timothy, Mortimer, Joanne, Weilbaecher, Katherine
Publicat 2010Text -
15
Ral signaling pathway in health and cancer per Moghadam, Adel Rezaei, Patrad, Elham, Tafsiri, Elham, Peng, Warner, Fangman, Benjamin, Pluard, Timothy J, Accurso, Anthony, Salacz, Michael, Shah, Kushal, Ricke, Brandon, Bi, Danse, Kimura, Kyle, Graves, Leland, Najad, Marzieh Khajoie, Dolatkhah, Roya, Sanaat, Zohreh, Yazdi, Mina, Tavakolinia, Naeimeh, Mazani, Mohammad, Amani, Mojtaba, Ghavami, Saeid, Gartell, Robyn, Reilly, Colleen, Naima, Zaid, Esfandyari, Tuba, Farassati, Faris
Publicat 2017Text -
16
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer per Ma, Cynthia X., Ellis, Matthew J. C., Petroni, Gina R., Guo, Zhanfang, Cai, Shi-rong, Ryan, Christine E., Craig Lockhart, A., Naughton, Michael J., Pluard, Timothy J., Brenin, Christiana M., Picus, Joel, Creekmore, Allison N., Mwandoro, Tibu, Yarde, Erin R., Reed, Jerry, Ebbert, Mark, Bernard, Philip S., Watson, Mark, Doyle, Laurence A., Dancey, Janet, Piwnica-Worms, Helen, Fracasso, Paula M.
Publicat 2012Text -
17
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surg... per Ellis, Matthew J., Suman, Vera J., Hoog, Jeremy, Goncalves, Rodrigo, Sanati, Souzan, Creighton, Chad J., DeSchryver, Katherine, Crouch, Erika, Brink, Amy, Watson, Mark, Luo, Jingqin, Tao, Yu, Barnes, Michael, Dowsett, Mitchell, Budd, G. Thomas, Winer, Eric, Silverman, Paula, Esserman, Laura, Carey, Lisa, Ma, Cynthia X., Unzeitig, Gary, Pluard, Timothy, Whitworth, Pat, Babiera, Gildy, Guenther, J. Michael, Dayao, Zoneddy, Ota, David, Leitch, Marilyn, Olson, John A., Allred, D. Craig, Hunt, Kelly
Publicat 2017Text -
18
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies per Fracasso, Paula M., Williams, Kerry J., Chen, Ronald C., Picus, Joel, Ma, Cynthia X., Ellis, Matthew J., Tan, Benjamin R., Pluard, Timothy J., Adkins, Douglas R., Naughton, Michael J., Rader, Janet S., Arquette, Matthew A., Fleshman, James W., Creekmore, Allison N., Goodner, Sherry A., Wright, Lisa P., Guo, Zhanfang, Ryan, Christine E., Tao, Yu, Soares, Eliane M., Cai, Shi-rong, Lin, Li, Dancey, Janet, Rudek, Michelle A., McLeod, Howard L., Piwnica-Worms, Helen
Publicat 2010Text -
19
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer per Ma, Cynthia X., Bose, Ron, Gao, Feng, Freedman, Rachel A., Telli, Melinda L., Kimmick, Gretchen, Winer, Eric, Naughton, Michael, Goetz, Matthew P., Russell, Christy, Tripathy, Debu, Cobleigh, Melody, Forero, Andres, Pluard, Timothy J., Anders, Carey, Niravath, Polly Ann, Thomas, Shana, Anderson, Jill, Bumb, Caroline, Banks, Kimberly C., Lanman, Richard B., Bryce, Richard, Lalani, Alshad S., Pfeifer, John, Hayes, Daniel F., Pegram, Mark, Blackwell, Kimberly, Bedard, Philippe L., Al-Kateb, Hussam, Ellis, Matthew J.C.
Publicat 2017Text -
20
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts per Li, Shunqiang, Shen, Dong, Shao, Jieya, Crowder, Robert, Liu, Wenbin, Prat, Aleix, He, Xiaping, Liu, Shuying, Hoog, Jeremy, Lu, Charles, Ding, Li, Griffith, Obi L., Miller, Christopher, Larson, Dave, Fulton, Robert S., Harrison, Michelle, Mooney, Tom, McMichael, Joshua F., Luo, Jingqin, Tao, Yu, Goncalves, Rodrigo, Schlosberg, Christopher, Hiken, Jeffrey F., Saied, Laila, Sanchez, Cesar, Giuntoli, Therese, Bumb, Caroline, Cooper, Crystal, Kitchens, Robert T., Lin, Austin, Phommaly, Chanpheng, Davies, Sherri R., Zhang, Jin, Kavuri, Megha Shyam, McEachern, Donna, Dong, Yi Yu, Ma, Cynthia, Pluard, Timothy, Naughton, Michael, Bose, Ron, Suresh, Rama, McDowell, Reida, Michel, Loren, Aft, Rebecca, Gillanders, William, DeSchryver, Katherine, Wilson, Richard K., Wang, Shaomeng, Mills, Gordon B., Gonzalez-Angulo, Ana, Edwards, John R., Maher, Christopher, Perou, Charles M., Mardis, Elaine R., Ellis, Matthew J.
Publicat 2013Text